(Q42446359)

English

Breast cancer classification according to immunohistochemical markers: clinicopathologic features and short-term survival analysis in a population-based study from the South of Switzerland

scientific article published on 12 December 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

31 October 2017

Breast cancer classification according to immunohistochemical markers: clinicopathologic features and short-term survival analysis in a population-based study from the South of Switzerland (English)

1 reference

Europe PubMed Central

31 October 2017

immunohistochemistry

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

A Spitale

1

1 reference

Europe PubMed Central

31 October 2017

P Mazzola

2

1 reference

Europe PubMed Central

31 October 2017

D Soldini

3

1 reference

Europe PubMed Central

31 October 2017

L Mazzucchelli

4

1 reference

Europe PubMed Central

31 October 2017

A Bordoni

5

1 reference

Europe PubMed Central

31 October 2017

publication date

12 December 2008

1 reference

Europe PubMed Central

31 October 2017

Annals of Oncology

1 reference

Europe PubMed Central

31 October 2017

20

1 reference

Europe PubMed Central

31 October 2017

628-635

1 reference

Europe PubMed Central

31 October 2017

4

1 reference

Europe PubMed Central

31 October 2017

Molecular portraits of human breast tumours

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN675

21 January 2018

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN675

21 January 2018

Repeated observation of breast tumor subtypes in independent gene expression data sets

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN675

21 January 2018

Breast cancer classification and prognosis based on gene expression profiles from a population-based study

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN675

21 January 2018

Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN675

21 January 2018

Epidemiology of basal-like breast cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN675

21 January 2018

Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN675

21 January 2018

Basal-HER2 phenotype shows poorer survival than basal-like phenotype in hormone receptor-negative invasive breast cancers

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN675

21 January 2018

Molecular classifications of breast carcinoma with similar terminology and different definitions: are they the same?

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN675

21 January 2018

Biology of progesterone receptor loss in breast cancer and its implications for endocrine therapy

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN675

21 January 2018

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN675

21 January 2018

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN675

21 January 2018

Use of trastuzumab for the treatment of early stage breast cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN675

21 January 2018

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN675

21 January 2018

Differences in risk factors for breast cancer molecular subtypes in a population-based study

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN675

21 January 2018

Completeness of cancer registration: a new method for routine use.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN675

21 January 2018

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN675

21 January 2018

Triple negative tumours: a critical review

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN675

21 January 2018

Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN675

21 January 2018

Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN675

21 January 2018

Expression of luminal and basal cytokeratins in human breast carcinoma

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN675

21 January 2018

Triple-negative breast cancer: clinical features and patterns of recurrence

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN675

21 January 2018

Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN675

21 January 2018

Demystifying basal-like breast carcinomas

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN675

21 January 2018

Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN675

21 January 2018

2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN675

21 January 2018

Morphologic and molecular evolutionary pathways of low nuclear grade invasive breast cancers and their putative precursor lesions: further evidence to support the concept of low nuclear grade breast neoplasia family

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN675

21 January 2018

Estimating the magnitude of trastuzumab effects within patient subgroups in the HERA trial

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN675

21 January 2018

Identifiers

10.1093/ANNONC/MDN675

1 reference

Europe PubMed Central

31 October 2017

1 reference

Europe PubMed Central

31 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42446359&oldid=1966933935"